Literature DB >> 11855555

Implementation of vaccination in patients with cirrhosis.

Miguel R Arguedas1, Brendan M McGuire, Michael B Fallon.   

Abstract

Vaccination for hepatitis A, hepatitis B, pneumococcus, and influenza in patients with chronic liver disease is recommended. Our purpose was to determine the degree of adherence to these recommendations in cirrhotics presenting for liver transplantation evaluation. Our sample consisted of 105 patients presenting for evaluation for liver transplantation. Data were obtained by medical record review and patient interview. The age of the patients was 52 +/- 9 years (mean +/- SD) and the Child-Pugh score was 9 +/- 2. Twenty-nine patients had natural immunity for hepatitis A. Of the remaining 76, 20 (26.3%) received vaccine. Of the 89 patients without evidence of prior exposure to hepatitis B, 23 (25.8%) received vaccine. Pneumococcal and influenza vaccination was performed in 36 (34%) and 58 (55%) respectively. In conclusion, vaccination for viral hepatitis, pneumococcus, and influenza not being consistently performed. Public health efforts aimed at raising awareness about implementing vaccination in these patients are strongly encouraged.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11855555     DOI: 10.1023/a:1013734525348

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  Hepatic decompensation in patients with cirrhosis during infection with influenza A.

Authors:  A Duchini; M E Viernes; L M Nyberg; R M Hendry; P J Pockros
Journal:  Arch Intern Med       Date:  2000-01-10

2.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  C B Bridges; A G Winquist; K Fukuda; N J Cox; J A Singleton; R A Strikas
Journal:  MMWR Recomm Rep       Date:  2000-04-14

3.  Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients.

Authors:  M R Arguedas; A Johnson; M A Eloubeidi; M B Fallon
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

4.  Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-10-01

5.  The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.

Authors:  R P Myers; J C Gregor; P J Marotta
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

Review 6.  [Retrospective and comparative study of pneumococcal bacteremia in patients with chronic hepatopathy].

Authors:  J M Ramos Rincón; M Cuenca Estrella; M L Fernández Guerrero
Journal:  An Med Interna       Date:  1996-07

7.  Immunogenicity of hepatitis A vaccine in decompensated liver disease.

Authors:  J A Dumot; D S Barnes; Z Younossi; S M Gordon; R K Avery; R E Domen; J M Henderson; W D Carey
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

8.  Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

Authors:  S Vento; T Garofano; C Renzini; F Cainelli; F Casali; G Ghironzi; T Ferraro; E Concia
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

Review 9.  Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?

Authors:  E B Keeffe
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

Review 10.  Risk of hepatitis A superinfection in patients with underlying liver disease.

Authors:  M P Manns; A Schüler
Journal:  Acta Gastroenterol Belg       Date:  1998 Apr-Jun       Impact factor: 1.316

View more
  7 in total

1.  Immunization needs of chronic liver disease patients seen in primary care versus specialist settings.

Authors:  R Jake Jacobs; Allen S Meyerhoff; Sammy Saab
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 2.  The management of patients awaiting liver transplantation.

Authors:  Ka-Kit Li; James Neuberger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-10-06       Impact factor: 46.802

Review 3.  Hepatitis B vaccine by intradermal route in non responder patients: an update.

Authors:  Martina Filippelli; Elena Lionetti; Alessia Gennaro; Angela Lanzafame; Teresa Arrigo; Carmelo Salpietro; Mario La Rosa; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 4.  Medical management of chronic liver diseases (CLD) in children (part II): focus on the complications of CLD, and CLD that require special considerations.

Authors:  Mortada H F El-Shabrawi; Naglaa M Kamal
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

5.  Efficacy of high-dose intra-dermal hepatitis B virus vaccine in previous vaccination non-responders with chronic liver disease.

Authors:  S Dhillon; C Moore; S D Li; A Aziz; A Kakar; A Dosanjh; A Beesla; L Murphy; D H Van Thiel
Journal:  Dig Dis Sci       Date:  2011-12-09       Impact factor: 3.487

6.  Quality of Care in Patients With Cirrhosis: Trends in Recommended Adult Vaccination Coverage.

Authors:  Eimad M Ahmmad; Lewis R Roberts
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-09-22

7.  Efficacy of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis B virus infection.

Authors:  B Sayyad; S M Alavian; F Najafi; T Mokhtari Azad; M H Ari Tabarestani; M Shirvani; B Behnava; M Afshrian; S Vaziri; A R Janbakhsh; F Mansouri; Sh Kaviani
Journal:  Iran Red Crescent Med J       Date:  2012-10-30       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.